Literature DB >> 29412740

Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells.

Hila Naaman1, Tatiana Rabinski1,2, Avi Yizhak3, Solly Mizrahi3, Yonat Shemer Avni1,4, Ran Taube1, Bracha Rager1, Yacov Weinstein1, Glenn Rall5, Jacob Gopas1,6, Rivka Ofir1,2.   

Abstract

In this study, we found that the measles virus (MV) can infect human-induced pluripotent stem cells (hiPSCs). Wild-type MV strains generally use human signaling lymphocyte activation molecule (SLAM; CD150) as a cellular receptor, while vaccine strains such as the Edmonston strain can use both CD150 and CD46 as receptors. It is not yet known how early in the embryonal differentiation stages these receptors are expressed. We established two hiPSCs (BGU-iPSCs and EMF-iPSCs) which express CD46 and CD150. Both cell types can be infected by MV to form persistent, noncytopathic cell lines that release infectious MV particles. Following MV persistent infection, BGU-iPSCs and EMF-iPSCs remain pluripotent and can differentiate in vitro into the three germ layers. This includes cells expressing the neuronal differentiation markers: NF68 and miRNA-124. Since the MV does not integrate into the cell's genome, it can be utilized as a vehicle to systematically introduce genes into iPSC, to dissect and to define factors regulating lineage differentiation.

Entities:  

Keywords:  human-induced pluripotent stem cells; measles virus; persistent infection

Mesh:

Substances:

Year:  2018        PMID: 29412740      PMCID: PMC5804099          DOI: 10.1089/cell.2017.0034

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  64 in total

1.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 2.  Transcription and processing of human microRNA precursors.

Authors:  Bryan R Cullen
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

Review 3.  Induced pluripotent stem cells from ALS patients for disease modeling.

Authors:  Jean-Philippe Richard; Nicholas J Maragakis
Journal:  Brain Res       Date:  2014-09-16       Impact factor: 3.252

4.  Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.

Authors:  Shin-ichi Yokota; Tamaki Okabayashi; Noriko Yokosawa; Nobuhiro Fujii
Journal:  FASEB J       Date:  2007-08-24       Impact factor: 5.191

5.  SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.

Authors:  Koji Hashimoto; Nobuyuki Ono; Hironobu Tatsuo; Hiroko Minagawa; Makoto Takeda; Kaoru Takeuchi; Yusuke Yanagi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.

Authors:  J Gopas; D Itzhaky; Y Segev; S Salzberg; B Trink; N Isakov; B Rager-Zisman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells.

Authors:  Yan Liu; Huisheng Liu; Conall Sauvey; Lin Yao; Ewa D Zarnowska; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2013-08-08       Impact factor: 13.491

8.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

Authors:  Adriana Sánchez-Danés; Yvonne Richaud-Patin; Iria Carballo-Carbajal; Senda Jiménez-Delgado; Carles Caig; Sergio Mora; Claudia Di Guglielmo; Mario Ezquerra; Bindiben Patel; Albert Giralt; Josep M Canals; Maurizio Memo; Jordi Alberch; José López-Barneo; Miquel Vila; Ana Maria Cuervo; Eduard Tolosa; Antonella Consiglio; Angel Raya
Journal:  EMBO Mol Med       Date:  2012-03-08       Impact factor: 12.137

9.  Nuclear reprogramming with a non-integrating human RNA virus.

Authors:  Christopher B Driscoll; Jason M Tonne; Moustafa El Khatib; Roberto Cattaneo; Yasuhiro Ikeda; Patricia Devaux
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

Review 10.  The Immune Response in Measles: Virus Control, Clearance and Protective Immunity.

Authors:  Diane E Griffin
Journal:  Viruses       Date:  2016-10-12       Impact factor: 5.048

View more
  4 in total

1.  Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent.

Authors:  Zainab Tayeh; Nativ Dudai; Alona Schechter; Vered Chalifa-Caspi; Simon Barak; Rivka Ofir
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

2.  Asteriscus graveolens Extract in Combination with Cisplatin/Etoposide/Doxorubicin Suppresses Lymphoma Cell Growth through Induction of Caspase-3 Dependent Apoptosis.

Authors:  Zainab Tayeh; Rivka Ofir
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

3.  Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination.

Authors:  Jamie McMahon; Ian M Mackay; Stephen B Lambert
Journal:  Viruses       Date:  2019-07-10       Impact factor: 5.048

4.  miRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency.

Authors:  Ramya Rallabandi; Brenna Sharp; Conrad Cruz; Qi Wang; Alexis Locsin; Christopher B Driscoll; Ella Lee; Tim Nelson; Patricia Devaux
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-29       Impact factor: 5.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.